

Immunocell Therapeutics Inc Email Formats
Biotechnology Research • • 1-10 Employees
Key Contact at Immunocell Therapeutics Inc
Joshua Kellner
Senior Director of MS&T and Technical Operations
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Nanotechnology, Biopharmaceutical, Cancer Research, Cell Culture, Tumor Immunology |
| Employees | 1-10 |
About Immunocell Therapeutics Inc
Immunocell Therapeutics is an allogeneic Gamma Delta T-cell therapy company featuring unique, proprietary, end-to-end bioinformatic, AI targeting, and manufacturing technologies to address solid tumors. We are a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) 2.0 target discovery engine to develop and commercialize cell therapies focusing on immuno-oncology. Immunocell Therapeutics is developing a multi-indication allogeneic cell therapy platform that exploits the natural potency of Gamma Delta T-cells to target solid tumors. Immunocell's DIAMOND® AI is where data science meets target identification to dramatically compress the years and hundreds of millions of dollars required to develop a live drug.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Immunocell Therapeutics Inc has never raised funding before.
Frequently asked questions
4.8
40,000 users



